Germaine Penders

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

B. Berkhout, S. Kostense, G. Weverling, 2004, AIDS.

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

S. Kostense, P. Quax, M. Havenga, 2003, Journal of Virology.

ViroSpot microneutralization assay for antigenic characterization of human influenza viruses.

M. Koopmans, G. Rimmelzwaan, R. Jeeninga, 2017, Vaccine.

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

S. Kostense, P. Quax, M. Havenga, 2003, Journal of Virology.

ViroSpot microneutralization assay for antigenic characterization of human influenza viruses.

M. Koopmans, G. Rimmelzwaan, R. Jeeninga, 2017, Vaccine.